Prestigious award validates Geisinger’s focus on accurate and timely clinical data
"Geisinger is proud to join a handful of healthcare organizations in the world to reach this level of analytics maturity. We strive to provide our patients with the best possible outcomes through innovative technologies and progressive use of data-driven decisions," said Geisinger Chief Information Officer John Kravitz. "Geisinger’s clinically integrated environment ensures data flows seamlessly from one department to another, prioritizing patient care."
HIMSS Analytics, a global healthcare IT market intelligence, research and standards organization, developed the AMAM as a methodology to measure and advance an organization's analytics capabilities. This international eight-stage (Stage 0 - Stage 7) model measures the capabilities an organization has gained from the installation of data warehousing technology and data governance to assure validated data as a foundation for traditional and creative applications.
Geisinger has achieved AMAM Stage 6, emphasizing a strong foundation of data content, infrastructure, data governance and analytics competency.
Only two organizations in the world have reached the next, prestigious AMAM Stage 7 -- Duke Health and University of North Carolina Health. Geisinger joins Rush Health in Chicago and King Faisal Specialist Hospital & Research Centre in Saudi Arabia as the next Stage 6 achievers.
The recognition complements Geisinger’s recent validation as a clinical inpatient Stage 7 health system, as tracked by the HIMSS Electronic Medical Record Adoption Model (EMRAM℠). The health system validated at Stage 7 for the outpatient adoption model as well. In contrast to AMAM validations, over 350 organizations have achieved EMRAM Stage 7.
"The future of healthcare delivery is in data analytics and personalized medicine, so we are honored to be recognized by HIMSS Analytics for this achievement," said Dr. Mark Poler, a Physician Informaticist participating in the HIMSS AMAM validation process. “This continued recognition shows Geisinger is building upon a foundation of improved care quality, safety and efficiency.”
One of the nation’s most innovative health services organizations, Geisinger serves more than 1.5 million patients in Pennsylvania and New Jersey. The system includes 13 hospital campuses, a nearly 600,000-member health plan, two research centers and the Geisinger Commonwealth School of Medicine. Geisinger is known for its focus on caring and innovative programs including the ProvenCare® best-practice approach to maximize quality, safety and value; ProvenHealth Navigator® advanced medical home; Springboard Health® population health program to improve the health of an entire community; ProvenExperience™ to provide refunds to patients unhappy with their care experience; and Geisinger’s MyCode® Community Health Initiative, the largest healthcare system-based precision health project in the world. With more than 215,000 volunteer participants enrolled, MyCode is conducting extensive research and returning medically actionable results to participants. A physician-led organization, with approximately 32,000 employees and more than 1,800 employed physicians, Geisinger leverages an estimated $12.7 billion positive annual impact on the Pennsylvania and New Jersey economies. Repeatedly recognized nationally for integration, quality and service, Geisinger has a long-standing commitment to patient care, medical education, research and community service. For more information, visit www.geisinger.org, or connect with us on Facebook, Instagram, LinkedIn and Twitter.
For media inquiries:
Media Relations Manager